Ozempic and Wegovy Price Concerns Spark Heated Senate Hearing
Ozempic and Wegovy Prices Under Scrutiny
During a recent Senate hearing, Sen. Bernie Sanders confronted Novo Nordisk's CEO, raising alarms over the exorbitant prices of Ozempic and Wegovy, critical drugs for diabetes management and weight loss.
Urgent Questions on Access and Pricing
Senator Sanders stressed that keeping these medicines at high prices could lead to significant preventable deaths in the US, questioning the morality behind such costs.
- Costs of Ozempic: $969 in the US compared to $155 in Canada
- Costs of Wegovy: $1,349 in the US compared to $186 in Denmark
With millions relying on these medications, Sanders' focus on affordability has highlighted the disparity in drug prices within different countries. The discussion draws attention to the pharmaceutical industry’s struggles with pricing models.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.